People · Operator
Named in public records as an officer, director or promoter · active 2014–2018 · Other Technology, Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Hit the Mark Inc. | — | Other Technology | Series A | $13.6M | $299.6M | 2014 |
| Biovie Inc. | — | Biotechnology | Series A | $10.5M | $81.1M | 2018 |
| Adheron Therapeutics, Inc. | — | Pharmaceuticals | Seed | $1.5M | $57.1M | 2015 |
Hari Kumar at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Hari Kumar on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Richard J. Berman | 1 | 8 |
| Jonathan Adams | 1 | 7 |
| Rajeev Dadoo | 1 | 7 |
| MICHAEL SHERMAN | 1 | 5 |
| Mina Sooch | 1 | 5 |
| Terren S. Peizer | 1 | 4 |
| Cuong Do | 1 | 4 |
| Terren Peizer | 1 | 4 |
| Julie Anderson | 1 | 3 |
| Ron Laufer | 1 | 3 |
| Steve J. Gorlin | 1 | 3 |
| Chris Thomajan | 1 | 3 |
| Samrat Ganguly | 1 | 2 |
| Doug Onsi | 1 | 2 |
| Isai Peimer | 1 | 2 |
| Rajah Menon | 1 | 2 |
| Michael S. Sherman | 1 | 2 |
| James Lang | 1 | 2 |
| Elliot Ehrlich | 1 | 1 |
| Bob Baltera | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.